- call +1-201-465-4211
- email sales@mrinsights.biz
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
Scope of the Report:
Asia-Pacific Antivenom market is valued at 285.00 million USD in 2017 and is expected to reach 359.23 million USD by the end of 2023, growing at a CAGR of 43.93% between 2016 and 2022.
The price of Antivenom is slightly increased in nearly five years. For being accorded with the corresponding application area, the product price has a large differences.
Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this areas, the future will still have more new investment enter the field.
The worldwide market for Antivenom is expected to grow at a CAGR of roughly 2.5% over the next five years, will reach 960 million US$ in 2024, from 830 million US$ in 2019, according to a new study.
This report focuses on the Antivenom in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
CSL Behring
Merck & Co.
BTG Plc
Pfizer
Haffkine Bio-Pharmaceutical Corporation
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Polyvalent antivenom
Monovalent antivenom
Market Segment by Applications, can be divided into
Retail Pharmacies
Hospitals
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antivenom product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antivenom, with price, sales, revenue and global market share of Antivenom in 2017 and 2018.
Chapter 3, the Antivenom competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antivenom breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Antivenom market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Antivenom sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Antivenom Introduction
1.2 Market Analysis by Type
1.2.1 Polyvalent antivenom
1.2.2 Monovalent antivenom
1.3 Market Analysis by Applications
1.3.1 Retail Pharmacies
1.3.2 Hospitals
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 Business Overview
2.1.2 Antivenom Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck & Co.
2.2.1 Business Overview
2.2.2 Antivenom Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck & Co. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 BTG Plc
2.3.1 Business Overview
2.3.2 Antivenom Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Antivenom Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Haffkine Bio-Pharmaceutical Corporation
2.5.1 Business Overview
2.5.2 Antivenom Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Rare Disease Therapeutics
2.6.1 Business Overview
2.6.2 Antivenom Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Flynn Pharma
2.7.1 Business Overview
2.7.2 Antivenom Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Vins Bioproducts
2.8.1 Business Overview
2.8.2 Antivenom Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Bharat Serums and Vaccines
2.9.1 Business Overview
2.9.2 Antivenom Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Serum Biotech
2.10.1 Business Overview
2.10.2 Antivenom Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Antivenom Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Antivenom Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Antivenom Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Antivenom Manufacturer Market Share in 2018
3.3.2 Top 6 Antivenom Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Antivenom Market Analysis by Regions
4.1 Global Antivenom Sales, Revenue and Market Share by Regions
4.1.1 Global Antivenom Sales and Market Share by Regions (2014-2019)
4.1.2 Global Antivenom Revenue and Market Share by Regions (2014-2019)
4.2 North America Antivenom Sales and Growth Rate (2014-2019)
4.3 Europe Antivenom Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Antivenom Sales and Growth Rate (2014-2019)
4.5 South America Antivenom Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Antivenom Sales and Growth Rate (2014-2019)
5 North America Antivenom by Country
5.1 North America Antivenom Sales, Revenue and Market Share by Country
5.1.1 North America Antivenom Sales and Market Share by Country (2014-2019)
5.1.2 North America Antivenom Revenue and Market Share by Country (2014-2019)
5.2 United States Antivenom Sales and Growth Rate (2014-2019)
5.3 Canada Antivenom Sales and Growth Rate (2014-2019)
5.4 Mexico Antivenom Sales and Growth Rate (2014-2019)
6 Europe Antivenom by Country
6.1 Europe Antivenom Sales, Revenue and Market Share by Country
6.1.1 Europe Antivenom Sales and Market Share by Country (2014-2019)
6.1.2 Europe Antivenom Revenue and Market Share by Country (2014-2019)
6.2 Germany Antivenom Sales and Growth Rate (2014-2019)
6.3 UK Antivenom Sales and Growth Rate (2014-2019)
6.4 France Antivenom Sales and Growth Rate (2014-2019)
6.5 Russia Antivenom Sales and Growth Rate (2014-2019)
6.6 Italy Antivenom Sales and Growth Rate (2014-2019)
7 Asia-Pacific Antivenom by Country
7.1 Asia-Pacific Antivenom Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Antivenom Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Antivenom Revenue and Market Share by Country (2014-2019)
7.2 China Antivenom Sales and Growth Rate (2014-2019)
7.3 Japan Antivenom Sales and Growth Rate (2014-2019)
7.4 Korea Antivenom Sales and Growth Rate (2014-2019)
7.5 India Antivenom Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Antivenom Sales and Growth Rate (2014-2019)
8 South America Antivenom by Country
8.1 South America Antivenom Sales, Revenue and Market Share by Country
8.1.1 South America Antivenom Sales and Market Share by Country (2014-2019)
8.1.2 South America Antivenom Revenue and Market Share by Country (2014-2019)
8.2 Brazil Antivenom Sales and Growth Rate (2014-2019)
8.3 Argentina Antivenom Sales and Growth Rate (2014-2019)
8.4 Colombia Antivenom Sales and Growth Rate (2014-2019)
9 Middle East and Africa Antivenom by Countries
9.1 Middle East and Africa Antivenom Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Antivenom Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Antivenom Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Antivenom Sales and Growth Rate (2014-2019)
9.3 Turkey Antivenom Sales and Growth Rate (2014-2019)
9.4 Egypt Antivenom Sales and Growth Rate (2014-2019)
9.5 Nigeria Antivenom Sales and Growth Rate (2014-2019)
9.6 South Africa Antivenom Sales and Growth Rate (2014-2019)
10 Global Antivenom Market Segment by Type
10.1 Global Antivenom Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Antivenom Sales and Market Share by Type (2014-2019)
10.1.2 Global Antivenom Revenue and Market Share by Type (2014-2019)
10.2 Polyvalent antivenom Sales Growth and Price
10.2.1 Global Polyvalent antivenom Sales Growth (2014-2019)
10.2.2 Global Polyvalent antivenom Price (2014-2019)
10.3 Monovalent antivenom Sales Growth and Price
10.3.1 Global Monovalent antivenom Sales Growth (2014-2019)
10.3.2 Global Monovalent antivenom Price (2014-2019)
11 Global Antivenom Market Segment by Application
11.1 Global Antivenom Sales Market Share by Application (2014-2019)
11.2 Retail Pharmacies Sales Growth (2014-2019)
11.3 Hospitals Sales Growth (2014-2019)
11.4 Others Sales Growth (2014-2019)
12 Antivenom Market Forecast (2019-2024)
12.1 Global Antivenom Sales, Revenue and Growth Rate (2019-2024)
12.2 Antivenom Market Forecast by Regions (2019-2024)
12.2.1 North America Antivenom Market Forecast (2019-2024)
12.2.2 Europe Antivenom Market Forecast (2019-2024)
12.2.3 Asia-Pacific Antivenom Market Forecast (2019-2024)
12.2.4 South America Antivenom Market Forecast (2019-2024)
12.2.5 Middle East and Africa Antivenom Market Forecast (2019-2024)
12.3 Antivenom Market Forecast by Type (2019-2024)
12.3.1 Global Antivenom Sales Forecast by Type (2019-2024)
12.3.2 Global Antivenom Market Share Forecast by Type (2019-2024)
12.4 Antivenom Market Forecast by Application (2019-2024)
12.4.1 Global Antivenom Sales Forecast by Application (2019-2024)
12.4.2 Global Antivenom Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Antivenom Picture
Table Product Specifications of Antivenom
Figure Global Sales Market Share of Antivenom by Types in 2018
Table Antivenom Types for Maj
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
